MEDDX | VEGBX | MEDDX / VEGBX | |
Total Expense Ratio | 1.81 | 0.35 | 517% |
Annual Report Gross Expense Ratio | 1.82 | 0.35 | 520% |
Fund Existence | 16 years | 7 years | - |
Gain YTD | 1.085 | 2.660 | 41% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 50000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.99B | 4.4B | 159% |
Annual Yield % from dividends | 5.77 | 6.88 | 84% |
Returns for 1 year | 5.34 | 7.19 | 74% |
Returns for 3 years | 16.37 | 26.87 | 61% |
Returns for 5 years | 7.78 | 21.17 | 37% |
Returns for 10 years | 21.37 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
OIGCX | 30.65 | N/A | N/A |
Invesco Oppenheimer International Gr C | |||
FICHX | 13.04 | N/A | N/A |
Cantor Fitzgerald Large Cap Fcs Cl Inst | |||
TNVAX | 16.28 | N/A | N/A |
1290 GAMCO Small/Mid Cap Value A | |||
BMCKX | 25.05 | N/A | N/A |
BlackRock Advantage Large Cap Gr K | |||
ELMCX | 17.13 | N/A | N/A |
Lord Abbett Emerging Markets Equity C |